Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 26.20
-2.45 (-8.55%)
At close: Nov 6, 2026
Anya Biopharm Market Cap
Anya Biopharm has a market cap or net worth of 1.29 billion as of November 6, 2026. It is the 31,609th most valuable company in the world and the 1,866th biggest in Taiwan. Its market cap has decreased by 47.81% in one year.
Market Cap
1.29B
Enterprise Value
972.68M
Revenue
13.06M
Global Rank
Country Rank
#1,866 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 25, 2024, Anya Biopharm's market cap has decreased from 2.85B to 1.29B, a decrease of -54.91%. That is a compound annual growth rate of -32.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.29B | -45.19% |
| Dec 31, 2025 | 2.35B | 26.96% |
| Dec 31, 2024 | 1.85B | -35.20% |
| Oct 25, 2024 | 2.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taho Pharmaceuticals | 12.34B |
| Pharmasaga | 6.32B |
| TEH SENG Pharmaceutical Mfg. | 2.24B |
| Protect Animal Health | 2.23B |
| Libo Pharma | 1.91B |
| Timing Pharmaceutial | 1.69B |
| Gin Hwa Biotech Incorporation | 1.61B |
| Anbogen Therapeutics | 1.54B |